Annals of Oncology

News:

Creation of a European drug development network
Ann Oncol 10: 365.
[PDF] [Request Permissions]

Marketing of temozolomide in Europe
Ann Oncol 10: 365.
[PDF] [Request Permissions]

What after managed care?
Ann Oncol 10: 365-366.
[PDF] [Request Permissions]

Europe for moratorium on xenotransplantation
Ann Oncol 10: 366.
[PDF] [Request Permissions]

Euthanasia advisory board in the Netherlands
Ann Oncol 10: 366-367.
[PDF] [Request Permissions]

Awards, appointments
Ann Oncol 10: 367.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 10: 367-371.
[PDF] [Request Permissions]

Book reviews:

R. Obrist

Book review
Ann Oncol 10: 372.
[PDF] [Request Permissions]

J. Bernier

Book review
Ann Oncol 10: 474.
[PDF] [Request Permissions]

Editorial:

C. Sessa

Rationing in cancer treatment: Is the identification of essential cytotoxic drugs feasible?
Ann Oncol 10: 373-374.
[PDF] [Request Permissions]

M. J. Ratain

Drug combinations: Dangerous liaisons or great expectations?
Ann Oncol 10: 375-376.
[PDF] [Request Permissions]

Review:

A. Hamilton and M. Piccart

The third-generation non-steroidal aromatase inhibitors: A review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer
Ann Oncol 10: 377-384.
[Abstract] [PDF] [Request Permissions]

Special articles:

K. Sikora, S. Advani, V. Koroltchouk, I. Magrath, L. Levy, H. Pinedo, G. Schwartsmann, M. Tattersall, and S. Yan

Essential drugs for cancer therapy: A World Health Organization consultation
Ann Oncol 10: 385-390.
[Abstract] [PDF] [Request Permissions]

Rapid publication:

T. Colombo, I. Parisi, M. Zucchetti, C. Sessa, A. Goldhirsch, and M. D'lncalci

Pharmacokinetic interactions of paclitaxel, docetaxel and their vehicles with doxorubicin
Ann Oncol 10: 391-395.
[Abstract] [PDF] [Request Permissions]

Original articles:

C. Vogel, M. O'Rourke, E. Winer, H. Hochster, A. Chang, B. Adamkiewicz, R. White, and C. McGuirt

Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older
Ann Oncol 10: 397-402.
[Abstract] [PDF] [Request Permissions]

F. A. Holmes, V. alero, R. S. Walters, R. L. Theriault, D. J. Booser, H. Gibbs, G. Fraschini, A. U. Buzdar, J. Willey, D. Frye, L. Asmar, and G. N. Hortobagyi

Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: Phase I results
Ann Oncol 10: 403-411.
[Abstract] [PDF] [Request Permissions]

D. Rayson, A. A. Adjei, V. J. Suman, L. E. Wold, and J. N. Ingle

Metaplastic breast cancer: Prognosis and response to systemic therapy
Ann Oncol 10: 413-419.
[Abstract] [PDF] [Request Permissions]

A. Hasbini, R. Mahjoubi, A. Fandi, N. Chouaki, A. Taamma, P. Lianes, H. Cortès-Funes, S. Alonso, J. P. Armand, E. Cvitkovic, and E. Raymond

Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngealtype
Ann Oncol 10: 421-425.
[Abstract] [PDF] [Request Permissions]

S. Cortelazzo, A. Rossi, P. Bellavita, E. Oldani, P. Viero, M. Buelli, A. Rambaldi, and T. Barbui

Clinical outcome after autologous transplantation in non-Hodgkin's lymphoma patients with high international prognostic index (IPI)
Ann Oncol 10: 427-432.
[Abstract] [PDF] [Request Permissions]

A. H. Sarris, K.-O. Kliche, P. Pethambaram, A. Preti, S. Tucker, C. Jackow, O. Messina, W. Pugh, F.B. Hagemeister, P. McLaughlin, M.-A. Rodriguez, J. Romaguera, H. Fritsche, T. Witzig, M. Duvic, M. Andreeff, and F. Cabanillas

Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival
Ann Oncol 10: 433-440.
[Abstract] [PDF] [Request Permissions]

C.J.A. van Moorsel, J.R. Kroep, H.M. Pinedo, G. Veerman, D.A. Voorn, P.E. Postmus, J. B. Vermorken, C.J. van Groeningen, W.J.F. van der Vijgh, and G.J. Peters

Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors
Ann Oncol 10: 441-448.
[Abstract] [PDF] [Request Permissions]

T. Petit, E. Izbicka, R.A. Lawrence, W.R. Bishop, S. Weitman, and D. D. Von Hoff

Activity of SCH 66336, a tricyclic farnesyltransferase inhibitor, against human tumor colony-forming units
Ann Oncol 10: 449-453.
[Abstract] [PDF] [Request Permissions]

T. Oguri, Y. Fujiwara, M. Miyazaki, T. Takahashi, T. Kurata, M. Yokozaki, N. Ohashi, T. Isobe, O. Katoh, and M. Yamakido

Induction of -glutamylcysteine synthetase gene expression by platinum drugs in peripheral mononuclear cells of lung cancer patients
Ann Oncol 10: 455-460.
[Abstract] [PDF] [Request Permissions]

Clinical case:

O. Breathnach, P. Donnellan, D. Collins, W. McNicholas, and J. Crown

Cytomegalovirus pneumonia in a patient with breast cancer on chemotherapy: Case report and review of the literature
Ann Oncol 10: 461-465.
[Abstract] [PDF] [Request Permissions]

Short report:

P. Barozzi, M. Luppi, K. Cagossi, A. Maiorana, R. Marasca, T. Artusi, S. Poggi, S. A. Pileri, and G. Torelli

The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign
Ann Oncol 10: 467-469.
[Abstract] [PDF] [Request Permissions]

P. Vineis, G. Masala, A. Seniori Costantini, and Working Group for the Epidemiology of Hematolymphopoietic Malignancies in Italy

Does a gene in the Xq28 region increase the risk of non-Hodgkin's lymphomas?
Ann Oncol 10: 471-473.
[PDF] [Request Permissions]

G. Fountzilas, G. Stathopoulos, C. Nicolaides, A. Kalogera-Fountzila, H. Kalofonos, A. Nikolaou, C. Bacoyiannis, E. Samantas, C. Papadimitriou, P. Kosmidis, J. Daniilidis, and N. Pavlidis

Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group
Ann Oncol 10: 475-478.
[Abstract] [PDF] [Request Permissions]

H. M. Prince, M. J. Millward, D. Rischin, D. Blakey, P. Francis, P. Gates, P. Chappie, M. Quinn, S. Juneja, M. Wolf, E. H. Januszewicz, J. F. Seymour, M. Brettell, A. Strickland, J. Zalcberg, G. Richardson, J. Scarlett, P. Briggs, and G. C. Toner

Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: Results of a phase I study
Ann Oncol 10: 479-481.
[Abstract] [PDF] [Request Permissions]

Letters to the editor:

Watchful monitoring for hepatitis B reactivation after intensive chemotheraphy
Ann Oncol 10: 483-484.
[PDF] [Request Permissions]

N. Patton, S. Chambers, and B. Chapman

Management of reactivated HBV infection following intensive chemotherapy for malignancy
Ann Oncol 10: 484.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.